BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15978777)

  • 1. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
    Ganor Y; Goldberg-Stern H; Lerman-Sagie T; Teichberg VI; Levite M
    Epilepsy Res; 2005 Jun; 65(1-2):11-22. PubMed ID: 15978777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
    Levite M; Ganor Y
    Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
    Ganor Y; Freilinger M; Dulac O; Levite M
    Autoimmunity; 2005 Mar; 38(2):139-50. PubMed ID: 16040334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy.
    Ganor Y; Goldberg-Stern H; Amrom D; Lerman-Sagie T; Teichberg VI; Pelled D; Futerman AH; Zeev BB; Freilinger M; Verheulpen D; Van Bogaert P; Levite M
    Clin Dev Immunol; 2004; 11(3-4):241-52. PubMed ID: 15559370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel.
    Levite M; Fleidervish IA; Schwarz A; Pelled D; Futerman AH
    J Autoimmun; 1999 Aug; 13(1):61-72. PubMed ID: 10441169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
    van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
    Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies in epilepsy and seizure-associated disorders.
    McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
    Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures.
    Ganor Y; Gottlieb M; Eilam R; Otmy H; Teichberg VI; Levite M
    Exp Neurol; 2005 Sep; 195(1):92-102. PubMed ID: 15907325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
    Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
    Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoantibodies to glutamate receptor subtypes--markers of functional brain damage: their diagnostic significance for detecting paroxysmal activity and ischemia].
    Dambinova SA; Izykenova GA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(2):439-46. PubMed ID: 9173747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific changes in levels of autoantibodies to glutamate and opiate receptors induced by morphine administration in rats.
    Granstrem O; Adriani W; Shumilina M; Izykenova G; Dambinova S; Laviola G
    Neurosci Lett; 2006 Jul; 403(1-2):1-5. PubMed ID: 16687214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) associate with some cognitive/psychiatric/behavioral abnormalities in epilepsy patients.
    Goldberg-Stern H; Ganor Y; Cohen R; Pollak L; Teichberg V; Levite M
    Psychoneuroendocrinology; 2014 Feb; 40():221-31. PubMed ID: 24485494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
    Steup-Beekman G; Steens S; van Buchem M; Huizinga T
    Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
    Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
    JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.
    Niehusmann P; Dalmau J; Rudlowski C; Vincent A; Elger CE; Rossi JE; Bien CG
    Arch Neurol; 2009 Apr; 66(4):458-64. PubMed ID: 19364930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies and epilepsy.
    Bien CG; Scheffer IE
    Epilepsia; 2011 May; 52 Suppl 3():18-22. PubMed ID: 21542841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.